ArticleDiagnostic microbiology and infectious disease2021

Evaluation of 2 commercial anti-SARS-CoV-2 antibody assays in an immunocompetent and immunocompromised inpatient population with COVID-19.

David Harrington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.